# Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

> **NCT01214343** · PHASE3 · UNKNOWN · sponsor: **Ministry of Health, Labour and Welfare, Japan** · enrollment: 190 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma
- Carcinoma
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Neoplasms

## Interventions

- **DRUG:** Sorafenib with Low-dose FP
- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT01214343
- **Lead sponsor:** Ministry of Health, Labour and Welfare, Japan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2011-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01214343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01214343, "Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01214343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*